ロード中...
Transcatheter Bioprosthetic Aortic Valve Dysfunction: What We Know So Far
Transcatheter aortic valve replacement (TAVR) is an established alternative to surgical valve replacement for patients with severe aortic stenosis (AS) and increased surgical risk. On the basis of the favorable outcomes of recent randomized clinical trials conducted in intermediate and low risk popu...
保存先:
| 出版年: | Front Cardiovasc Med |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6787554/ https://ncbi.nlm.nih.gov/pubmed/31637246 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2019.00145 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|